Dr. LI Ning holds a Ph.D. in Oncology from Peking Union Medical College, Cancer Hospital Chinese Academy of Medical Sciences (National Cancer Center). Since graduating in 2015, she has been practicing in the Department of Medical Oncology at the First Affiliated Hospital of Zhejiang University School of Medicine.

Her clinical expertise encompasses the medical treatment of various solid tumors, including lung cancer, breast cancer, gastric cancer, esophageal cancer, colorectal cancer, hepatobiliary-pancreatic tumors, and sarcoma. She also specializes in the comprehensive management of treatment-related adverse effects, such as gastrointestinal reactions and hematologic toxicity, following chemotherapy for malignant tumors.

Dr. Li has presided over and completed a research project funded by the Zhejiang Provincial Natural Science Foundation for Young Scholars. She has published more than 10 papers in domestic and international journals, including Journal for ImmunoTherapy of Cancer and American Journal of Cancer Research.

l Committee Member, International Education and Training Branch, China International Exchange and Promotive Association for Medical and Health Care

l Committee Member, Professional Committee on Cancer Immunotherapy, Beijing Association for Chronic Disease Prevention, Control and Health Education

l Sixth-Term Editorial Board Member, Chinese Journal of Clinical Oncology and Rehabilitation